Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-091477
Filing Date
2016-03-30
Accepted
2016-03-30 16:01:39
Documents
76
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v434593_10k.htm 10-K 938350
2 EXHIBIT 23.1 v434593_ex23-1.htm EX-23.1 2131
3 EXHIBIT 31.1 v434593_ex31-1.htm EX-31.1 11022
4 EXHIBIT 32.1 v434593_ex32-1.htm EX-32.1 3992
  Complete submission text file 0001144204-16-091477.txt   6568733

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arni-20151231.xml EX-101.INS 1613082
6 XBRL TAXONOMY EXTENSION SCHEMA arni-20151231.xsd EX-101.SCH 71868
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arni-20151231_cal.xml EX-101.CAL 47604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arni-20151231_def.xml EX-101.DEF 336532
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arni-20151231_lab.xml EX-101.LAB 461860
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arni-20151231_pre.xml EX-101.PRE 394065
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Filer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52153 | Film No.: 161539546
SIC: 2834 Pharmaceutical Preparations